Myomo Inc (MYO) - Total Assets
Based on the latest financial reports, Myomo Inc (MYO) holds total assets worth $36.75 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Myomo Inc - Total Assets Trend (2014–2025)
This chart illustrates how Myomo Inc's total assets have evolved over time, based on quarterly financial data. Also see MYO market cap for the company's overall valuation and market capitalisation.
Myomo Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Myomo Inc's total assets of $36.75 Million consist of 71.3% current assets and 28.7% non-current assets. Review Myomo Inc (MYO) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $14.13 Million | 36.6% |
| Accounts Receivable | $4.10 Million | 10.6% |
| Inventory | $3.12 Million | 8.1% |
| Property, Plant & Equipment | $8.89 Million | 23.0% |
| Intangible Assets | $1.59 Million | 4.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Myomo Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See MYO stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Myomo Inc's current assets represent 71.3% of total assets in 2025, a decrease from 94.5% in 2014.
- Cash Position: Cash and equivalents constituted 36.6% of total assets in 2025, down from 79.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is cash and equivalents at 36.6% of total assets.
Myomo Inc Competitors by Total Assets
Key competitors of Myomo Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
TransMedics Group Inc
NASDAQ:TMDX
|
USA | $1.46 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
|
China | CN¥2.70 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
Myomo Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.73 | 2.66 | 5.17 |
| Quick Ratio | 2.36 | 2.38 | 4.94 |
| Cash Ratio | 0.00 | 1.70 | 4.28 |
| Working Capital | $16.27 Million | $19.42 Million | $13.41 Million |
Myomo Inc - Advanced Valuation Insights
This section examines the relationship between Myomo Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.55 |
| Latest Market Cap to Assets Ratio | 0.85 |
| Asset Growth Rate (YoY) | -8.5% |
| Total Assets | $38.64 Million |
| Market Capitalization | $32.84 Million USD |
Valuation Analysis
Near Book Valuation: The market values Myomo Inc's assets close to their book value (0.85x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Myomo Inc's assets decreased by 8.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Myomo Inc (2014–2025)
The table below shows the annual total assets of Myomo Inc from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $38.64 Million | -8.54% |
| 2024-12-31 | $42.24 Million | +189.71% |
| 2023-12-31 | $14.58 Million | +43.49% |
| 2022-12-31 | $10.16 Million | -49.43% |
| 2021-12-31 | $20.10 Million | +36.61% |
| 2020-12-31 | $14.71 Million | +122.92% |
| 2019-12-31 | $6.60 Million | -20.32% |
| 2018-12-31 | $8.28 Million | -40.74% |
| 2017-12-31 | $13.97 Million | +742.75% |
| 2016-12-31 | $1.66 Million | +9.90% |
| 2015-12-31 | $1.51 Million | -50.45% |
| 2014-12-31 | $3.05 Million | -- |
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more